Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review.
Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review.
复制标题
DOI:
10.1016/j.pmedr.2023.102111
复制
发表时间:
2023-04
影响因子:
2.8
通讯作者:
McFarland, Mary M.
中科院分区:
文献类型:
--
作者:
Charron, Elizabeth;Kent-Marvick, Jacqueline;Gibson, Tyler;Taylor, Eliza;Bouwman, Kelsey;Sani, Gelina M.;Simonsen, Sara E.;Stone, Rebecca H.;Kaiser, Jennifer E.;McFarland, Mary M.
关键词:
Women who use opioids (WWUO) suboptimally access and use effective contraception. We mapped 28 studies identifying contraceptive barriers and facilitators for WWUO. Contraceptive barriers and facilitators for WWUO exist at many levels of influence. We identified no studies that included participants from marginalized groups. Future research should target more diverse populations in community settings. Existing research has found that women who use opioids (WWUO) experience challenges to hormonal and long-acting reversible contraception (HC-LARC) access and use. Facilitators of such use are unclear. We conducted a scoping review to comprehensively map the literature on barriers to and facilitators of HC-LARC access and use in the United States among reproductive-aged WWUO. In accordance with the JBI Manual of Evidence Synthesis, we conducted literature searches for empirical articles published from 1990 to 2021. Independent reviewers screened references, first by titles and abstracts, then by full-text, and charted data of eligible articles. We coded and organized HC-LARC barriers and facilitators according to a four-level social-ecological model (SEM) and categorized findings within each SEM level into domains. We screened 4,617 records, of which 28 articles focusing on HC-LARC (n = 18), LARC only (n = 6), or testing an intervention to increase HC-LARC uptake (n = 4) met inclusion criteria. We identified 13 domains of barriers and 11 domains of facilitators across four SEM levels (individual, relationship, community, societal). The most frequently cited barriers and facilitators were methods characteristics, partner and provider relations, transportation, healthcare availability and accessibility, cost, insurance, and stigma. Future studies would benefit from recruiting participants and collecting data in community settings, targeting more diverse populations, and identifying neighborhood, social, and policy barriers and facilitators. Reducing barriers and improving equity in HC-LARC access and use among WWUO is a complex, multifaceted issue that will require targeting factors simultaneously at multiple levels of the social-ecological hierarchy to effect change.
登录
查看更多内容
影响因子:
2.9
作者:
Brown, Benjamin P.;Chor, Julie;Whitaker, Amy K.
通讯作者:
Whitaker, Amy K.
影响因子:
1.8
作者:
Coates, Charrelle;Gordon, Catherine M.;Simpson, Tina
通讯作者:
Simpson, Tina
影响因子:
2.9
作者:
Gipson, Jessica D.;Bornstein, Marta;Rocca, Corinne H.
通讯作者:
Rocca, Corinne H.
DOI:
10.1177/0890117120927327
发表时间:
2020-11
期刊:
American journal of health promotion : AJHP
影响因子:
--
作者:
Hurley EA;Duello A;Finocchario-Kessler S;Goggin K;Stancil S;Winograd RP;Miller MK
通讯作者:
Miller MK
影响因子:
12.7
作者:
Jarlenski, Marian;Barry, Colleen L.;Kozhimannil, Katy
通讯作者:
Kozhimannil, Katy